THE EFFECT OF MITOMYCIN-C ON SUPERFICIAL BLADDER-CANCER

被引：62

作者：

SOLOWAY, MS

MURPHY, WM

DEFURIA, MD

CROOKE, S

FINEBAUM, P

机构：

[1] BAPTIST MEM HOSP,DEPT PATHOL,MEMPHIS,TN 38146

[2] BRISTOL MYERS CO LABS,DEPT CLIN RES,SYRACUSE,NY 13201

来源：

JOURNAL OF UROLOGY | 1981年 / 125卷 / 05期

关键词：

D O I：

10.1016/S0022-5347(17)55149-6

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：646 / 648

页数：3

共 50 条

[21] EFFECT OF INTRAVESICAL MITOMYCIN-C ON RECURRENCE OF NEWLY DIAGNOSED SUPERFICIAL BLADDER-CANCER - INTERIM-REPORT FROM THE MEDICAL-RESEARCH COUNCIL SUBGROUP ON SUPERFICIAL BLADDER-CANCER (UROLOGICAL CANCER WORKING PARTY)
TOLLEY, DA
HARGREAVE, TB
SMITH, PH
WILLIAMS, JL
GRIGOR, KM
PARMAR, MKB
FREEDMAN, LS
USCINSKA, BM
[J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6639) : 1759 - 1761
[22] MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER - IS LONG-TERM MAINTENANCE THERAPY WORTHWHILE AFTER INITIAL TREATMENT
HAMDY, FC
HASTIE, KJ
KERRY, R
WILLIAMS, JL
[J]. BRITISH JOURNAL OF UROLOGY, 1993, 71 (02): : 183 - 186
[23] INVITRO STUDY OF THE INTERACTION OF DOXORUBICIN, THIOTEPA, AND MITOMYCIN-C, AGENTS USED FOR INTRAVESICAL CHEMOTHERAPY OF SUPERFICIAL BLADDER-CANCER
SERAPHIM, LA
PERRAPATO, SD
SLOCUM, HK
RUSTUM, YM
HUBEN, RP
[J]. JOURNAL OF UROLOGY, 1991, 145 (03) : 613 - 617
[24] SUBSEQUENT TUMOR-ANALYSIS OF 36 PATIENTS WHO HAVE RECEIVED INTRAVESICAL MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER
SOLOWAY, MS
FORD, KS
[J]. JOURNAL OF UROLOGY, 1983, 130 (01) : 74 - 78
[25] INTRAVESICAL LONG-TERM CHEMOPROPHYLAXIS WITH MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER - RECURRENCE AND PROGRESSION AFTER 3 YEARS
RASSWEILER, J
HATH, U
BUB, P
EISENBERGER, F
[J]. AKTUELLE UROLOGIE, 1988, 19 (03) : 139 - 144
[26] TREATMENT SCHEDULE OF INTRAVESICAL CHEMOTHERAPY WITH MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER - SHORT-TERM COURSES OR MAINTENANCE THERAPY
VANDERMEIJDEN, APM
DEBRUYNE, FMJ
[J]. UROLOGY, 1988, 31 (03) : 26 - 29
[27] TREATMENT OF SUPERFICIAL BLADDER-CANCER WITH INTRAVESICAL MITOMYCIN-C - ANALYSIS OF IMMEDIATE AND LONG-TERM RESPONSE IN 70 PATIENTS
SOLOWAY, MS
[J]. JOURNAL OF UROLOGY, 1985, 134 (06) : 1107 - 1109
[28] MITOMYCIN-C INTRAVESICAL THERAPY IN NONINVASIVE BLADDER-CANCER AFTER FAILURE ON THIOTEPA
ISSELL, BF
PROUT, GR
SOLOWAY, MS
CUMMINGS, KB
BRANNEN, G
VEENEMA, R
FLANAGAN, M
BLOCK, NL
SUMMERS, JL
LEVIN, EA
DEFURIA, MD
[J]. CANCER, 1984, 53 (05) : 1025 - 1028
[29] PROGNOSTIC-SIGNIFICANCE OF URINE CYTOLOGY ON INITIAL FOLLOW-UP AFTER INTRAVESICAL MITOMYCIN-C FOR SUPERFICIAL BLADDER-CANCER
CANT, JD
MURPHY, WM
SOLOWAY, MS
[J]. CANCER, 1986, 57 (11) : 2119 - 2122
[30] USE OF PHARMACOLOGICAL DATA AND COMPUTER-SIMULATIONS TO DESIGN AN EFFICACY TRIAL OF INTRAVESICAL MITOMYCIN-C THERAPY FOR SUPERFICIAL BLADDER-CANCER
WIENTJES, MG
BADALAMENT, RA
AU, JLS
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (04) : 255 - 262

← 1 2 3 4 5 →